Only two cytokines (Interleukin-2 receptor, alpha subunit (IL − 2rα), and interferon gamma-induced protein 10 (IP-10) revealed suggestive associations with MPN risk after the Bonferroni correction. The gene discussed is CXCL10; the disease is myeloproliferative neoplasm.